CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is characterized by significant vascularization and immunogenicity, which contributes to drug resistance and immune escape. CD248, a pericytes marker in tumor vasculature, might help explain tumor microenvironment (TME) remodeling and serve as a novel therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shaojie, Xu, Chao, Zhang, Keying, Han, Donghui, Yang, Fa, Li, Yu, Zhao, Xiaolong, Ma, Shanjin, Li, Hongji, Lu, Shiqi, Lu, Tong, Zhang, Jiayu, Qin, Weijun, Wen, Weihong, Yang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743697/
https://www.ncbi.nlm.nih.gov/pubmed/35071435
http://dx.doi.org/10.21037/atm-21-6271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743697/
https://www.ncbi.nlm.nih.gov/pubmed/35071435
http://dx.doi.org/10.21037/atm-21-6271

Ejemplares similares